DAX
±0,00
%
Gold
±0,00
%
BörsenNEWS.de
Home
Börse
Märkte
Trends
Aktien
Indizes
Rohstoffe
Crypto
Derivate
Analyse
Niedrigstes KGV
Beste Dividende
Marktkapitalisierung
Meistgehandelt
Beste Performance
Termine
Handelskalender
Verfallstage
Community
Foren Übersicht
Meistdiskutiert
Community
News
Aktien
Indizes
Rohstoffe
Fonds
Anleihen
Zertifikate
Optionsscheine
Devisen
Crypto
News
Schlagzeilen
Nachrichten
Community
Meldungen
DAX-News
Dow Jones-News
MDAX-News
Märkte
Aktien
Indizes
Rohstoffe
Devisen
Partner
Archiv
KI-Fragen
Suche
SMARTBROKER
+
Depot
Suche
BörsenNEWS.de
Home
Suche
Suche
Sofort finden was Sie suchen
Alles
News
Aktie
Aktie
APPLIED GENETIC TECHNOL. CO
A110V2 / US03820J1007
0,39
USD
+1,23
%
News
Syngenta Group Reports Q1 2024 Results
News
Relief Therapeutics and World Orphan Drug Alliance Announce an Exclusive, Long-Term, Distribution Agreement to Introduce PKU GOLIKE® in the Middle East
News
Relief Therapeutics Announces Full Year 2022 Financial Results and Provides Corporate Update
News
Relief Therapeutics Appoints World-Renowned Gene Therapy Pioneer Guangping Gao, Ph.D. as Chair of Scientific Advisory Board
News
Relief Therapeutics Holding SA to Hold Extraordinary General Meeting of Shareholders
News
Relief Therapeutics Announces Executive Leadership Team Change
News
Relief Therapeutics Announces Survey Results Identifying Preferred Urea Cycle Disorder Treatment Attributes Presented by Collaboration Partner at SIMD 2023
News
Relief Therapeutics Provides Update From Collaboration Partner on OLPRUVA™
News
Relief Therapeutics Announces Availability of New PKU GOLIKE BARs in Europe
News
Relief Therapeutics to Present Pre-Clinical Evidence for Improved Amino Acid Utilization with PKU GOLIKE at the Society for Inherited Metabolic Disorders 44th Annual Meeting
News
Syngenta Group Reports Q1 2024 Results
News
Relief Therapeutics and World Orphan Drug Alliance Announce an Exclusive, Long-Term, Distribution Agreement to Introduce PKU GOLIKE® in the Middle East
News
Relief Therapeutics Announces Full Year 2022 Financial Results and Provides Corporate Update
News
Relief Therapeutics Announces Executive Leadership Team Change
News
Relief Therapeutics Holding SA to Hold Extraordinary General Meeting of Shareholders
News
Relief Therapeutics Appoints World-Renowned Gene Therapy Pioneer Guangping Gao, Ph.D. as Chair of Scientific Advisory Board
News
Relief Therapeutics Announces Survey Results Identifying Preferred Urea Cycle Disorder Treatment Attributes Presented by Collaboration Partner at SIMD 2023
News
Relief Therapeutics to Present Pre-Clinical Evidence for Improved Amino Acid Utilization with PKU GOLIKE at the Society for Inherited Metabolic Disorders 44th Annual Meeting
News
Relief Therapeutics Announces Availability of New PKU GOLIKE BARs in Europe
News
Relief Therapeutics Provides Update From Collaboration Partner on OLPRUVA™
Aktie
APPLIED GENETIC TECHNOL. CO
A110V2 / US03820J1007
0,39
USD
+1,23
%
Anmelden
Login
Neu hier?
Jetzt Registrieren
Passwort vergessen?
weiter